Perspective Therapeutics (CATX)

• Market cap: $480M
• 1 day: -3.22%
• 5 days: -7.06%
• 1 month: -19.35%
• 3 months: 60.69%
• 6 months: -13.02%
• Year to date: 50.9%
• 1 year: 105.37%
• 5 years: -59.13%
• 10 years: -55.21%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 166